Feige, J.; Berek, K.; Seiberl, M.; Hilpold, P.; Hitzl, W.; Di Pauli, F.; Hegen, H.; Deisenhammer, F.; Trinka, E.; Harrer, A.;
et al. Humoral Response to SARS-CoV-2 Antigen in Patients Treated with Monoclonal Anti-CD20 Antibodies: It Is Not All about B Cell Recovery. Neurol. Int. 2022, 14, 943-951.
https://doi.org/10.3390/neurolint14040075
AMA Style
Feige J, Berek K, Seiberl M, Hilpold P, Hitzl W, Di Pauli F, Hegen H, Deisenhammer F, Trinka E, Harrer A,
et al. Humoral Response to SARS-CoV-2 Antigen in Patients Treated with Monoclonal Anti-CD20 Antibodies: It Is Not All about B Cell Recovery. Neurology International. 2022; 14(4):943-951.
https://doi.org/10.3390/neurolint14040075
Chicago/Turabian Style
Feige, Julia, Klaus Berek, Michael Seiberl, Patrick Hilpold, Wolfgang Hitzl, Franziska Di Pauli, Harald Hegen, Florian Deisenhammer, Eugen Trinka, Andrea Harrer,
and et al. 2022. "Humoral Response to SARS-CoV-2 Antigen in Patients Treated with Monoclonal Anti-CD20 Antibodies: It Is Not All about B Cell Recovery" Neurology International 14, no. 4: 943-951.
https://doi.org/10.3390/neurolint14040075
APA Style
Feige, J., Berek, K., Seiberl, M., Hilpold, P., Hitzl, W., Di Pauli, F., Hegen, H., Deisenhammer, F., Trinka, E., Harrer, A., Wipfler, P., & Moser, T.
(2022). Humoral Response to SARS-CoV-2 Antigen in Patients Treated with Monoclonal Anti-CD20 Antibodies: It Is Not All about B Cell Recovery. Neurology International, 14(4), 943-951.
https://doi.org/10.3390/neurolint14040075
